GlassScriptPhysician profile
Ashley Park
NPI 1730926155
$4,136.15
in general payments reported to CMS, 2019-2025
19 companies · $3,285 in 2025
The $3,285 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $851 · 2025: $3,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,037 · Education: $99.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,036.89 |
| Education | $99.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $961.95 | 2024-2025 | Dupixent |
| Abbvie INC. | $616.68 | 2024-2025 | |
| Galderma Laboratories, L.P. | $539.81 | 2024-2025 | Nemluvio |
| Ucb, INC. | $313.58 | 2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $312.52 | 2025 | Zoryve |
| Genzyme Corporation | $283.16 | 2025 | |
| Lilly USA, LLC | $203.99 | 2024-2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $168.30 | 2025 | Anzupgo |
| Sun Pharmaceutical Industries INC. | $160.68 | 2024-2025 | |
| Janssen Biotech, INC. | $112.83 | 2024 | Tremfya |
| Organon LLC | $109.22 | 2025 | Vtama |
| Pfizer INC. | $77.90 | 2025 | |
| Incyte Corporation | $77.62 | 2025 | Opzelura |
| Amgen INC. | $72.86 | 2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $38.99 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $29.54 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $21.23 | 2024 | Sotyktu |
| Dermavant Sciences, INC. | $20.94 | 2024 | Vtama |
| Fidia Pharma USA INC. | $14.35 | 2024 | Triluron, Hymovis, Hyalgan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.